Roizen NJ, Patterson D (2003) Down’s syndrome. Lancet 361:1281–1289. https://doi.org/10.1016/S0140-6736(03)12987-X
Article
PubMed
Google Scholar
de Graaf G, Buckley F, Skotko BG (2017) Estimation of the number of people with Down syndrome in the United States. Genet Med 19:439–447. https://doi.org/10.1038/gim.2016.127
Article
PubMed
Google Scholar
Bittles AH, Glasson EJ (2004) Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol 46:282–286
CAS
Article
Google Scholar
Glasson EJ, Jacques A, Wong K et al (2016) Improved survival in Down syndrome over the last 60 years and the impact of perinatal factors in recent decades. J Pediatr 169:214–220.e1. https://doi.org/10.1016/j.jpeds.2015.10.083
Article
PubMed
Google Scholar
Leonard S, Bower C, Petterson B, Leonard H (2000) Survival of infants born with Down’s syndrome: 1980-96. Paediatr Perinat Epidemiol 14:163–171
CAS
Article
Google Scholar
Yang Q, Rasmussen SA, Friedman JM (2002) Mortality associated with Down’s syndrome in the USA from 1983 to 1997: a population-based study. Lancet 359:1019–1025
Article
Google Scholar
O’Leary L, Hughes-McCormack L, Dunn K, Cooper S-A (2018) Early death and causes of death of people with Down syndrome: a systematic review. J Appl Res Intellect Disabil 31:687–708. https://doi.org/10.1111/jar.12446
Article
PubMed
Google Scholar
Strauss D, Eyman RK (1996) Mortality of people with mental retardation in California with and without Down syndrome, 1986-1991. Am J Ment Retard 100:643–653
CAS
PubMed
Google Scholar
Dyer CA, Sinclair AJ (1998) The premature ageing syndromes: insights into the ageing process. Age Ageing 27:73–80
CAS
Article
Google Scholar
Martin GM (1982) Syndromes of accelerated aging. Natl Cancer Inst Monogr 60:241–247
CAS
PubMed
Google Scholar
Martin GM (1978) Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth Defects Orig Artic Ser 14:5–39
CAS
PubMed
Google Scholar
Patterson D, Cabelof DC (2012) Down syndrome as a model of DNA polymerase beta haploinsufficiency and accelerated aging. Mech Ageing Dev 133:133–137. https://doi.org/10.1016/j.mad.2011.10.001
CAS
Article
PubMed
Google Scholar
Zigman WB (2013) Atypical aging in Down syndrome. Dev Disabil Res Rev 18:51–67. https://doi.org/10.1002/ddrr.1128
Article
PubMed
Google Scholar
Esbensen AJ (2010) Health conditions associated with aging and end of life of adults with Down syndrome. Int Rev Res Ment Retard 39:107–126. https://doi.org/10.1016/S0074-7750(10)39004-5
Article
PubMed
PubMed Central
Google Scholar
Ballard C, Mobley W, Hardy J, Williams G, Corbett A (2016) Dementia in Down’s syndrome. Lancet Neurol 15:622–636. https://doi.org/10.1016/S1474-4422(16)00063-6
Article
PubMed
Google Scholar
Torr J, Strydom A, Patti P, Jokinen N (2010) Aging in Down syndrome: morbidity and mortality. Journal of Policy and Practice in Intellectual Disabilities 7:70–81. https://doi.org/10.1111/j.1741-1130.2010.00249.x
Article
Google Scholar
Franceschi C, Garagnani P, Gensous N, Bacalini MG, Conte M, Salvioli S (2019) Accelerated bio-cognitive aging in Down syndrome: state of the art and possible deceleration strategies. Aging Cell 18:e12903. https://doi.org/10.1111/acel.12903
CAS
Article
PubMed
PubMed Central
Google Scholar
Horvath S, Garagnani P, Bacalini MG, Pirazzini C, Salvioli S, Gentilini D, di Blasio AM, Giuliani C, Tung S, Vinters HV, Franceschi C (2015) Accelerated epigenetic aging in Down syndrome. Aging Cell 14:491–495. https://doi.org/10.1111/acel.12325
CAS
Article
PubMed
PubMed Central
Google Scholar
Obeid R, Hübner U, Bodis M, Geisel J (2016) Plasma amyloid beta 1-42 and DNA methylation pattern predict accelerated aging in young subjects with Down syndrome. NeuroMolecular Med 18:593–601. https://doi.org/10.1007/s12017-016-8413-y
CAS
Article
PubMed
Google Scholar
Borelli V, Vanhooren V, Lonardi E, Reiding KR, Capri M, Libert C, Garagnani P, Salvioli S, Franceschi C, Wuhrer M (2015) Plasma N-glycome signature of Down syndrome. J Proteome Res 14:4232–4245. https://doi.org/10.1021/acs.jproteome.5b00356
CAS
Article
PubMed
Google Scholar
Cole JH, Annus T, Wilson LR, Remtulla R, Hong YT, Fryer TD, Acosta-Cabronero J, Cardenas-Blanco A, Smith R, Menon DK, Zaman SH, Nestor PJ, Holland AJ (2017) Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline. Neurobiol Aging 56:41–49. https://doi.org/10.1016/j.neurobiolaging.2017.04.006
CAS
Article
PubMed
PubMed Central
Google Scholar
Hilton JM, Fitzgerald DA, Cooper DM (1999) Respiratory morbidity of hospitalized children with Trisomy 21. J Paediatr Child Health 35:383–386. https://doi.org/10.1046/j.1440-1754.1999.00386.x
CAS
Article
PubMed
Google Scholar
Mitwalli M, Wahba Y, Shaltout A, Gouida M (2018) Lymphocyte subgroups and recurrent infections in children with Down syndrome-a prospective case control study. Cent Eur J Immunol 43:248–254. https://doi.org/10.5114/ceji.2018.80042
CAS
Article
PubMed
PubMed Central
Google Scholar
Ram G, Chinen J (2011) Infections and immunodeficiency in Down syndrome. Clin Exp Immunol 164:9–16. https://doi.org/10.1111/j.1365-2249.2011.04335.x
CAS
Article
PubMed
PubMed Central
Google Scholar
Guffroy A, Dieudonné Y, Uring-Lambert B, Goetz J, Alembik Y, Korganow AS (2019) Infection risk among adults with Down syndrome: a two group series of 101 patients in a tertiary center. Orphanet J Rare Dis 14:15. https://doi.org/10.1186/s13023-018-0989-x
Article
PubMed
PubMed Central
Google Scholar
Kusters MA, Jol-Van Der Zijde ECM, Gijsbers RHJM, de Vries E (2011) Decreased response after conjugated meningococcal serogroup C vaccination in children with Down syndrome. Pediatr Infect Dis J 30:818–819. https://doi.org/10.1097/INF.0b013e31822233f9
Article
PubMed
Google Scholar
Kusters MA, Bok VLA, Bolz WEA, Huijskens EGW, Peeters MF, de Vries E (2012) Influenza A/H1N1 vaccination response is inadequate in Down syndrome children when the latest cut-off values are used. Pediatr Infect Dis J 31:1284–1285. https://doi.org/10.1097/INF.0b013e3182737410
Article
PubMed
Google Scholar
Kusters MA, Jol-van der Zijde CM, van Tol MJ et al (2011) Impaired avidity maturation after tetanus toxoid booster in children with Down syndrome. Pediatr Infect Dis J 30:357–359. https://doi.org/10.1097/INF.0b013e3181ff85a8
Article
PubMed
Google Scholar
Valentini D, Marcellini V, Bianchi S, Villani A, Facchini M, Donatelli I, Castrucci MR, Marasco E, Farroni C, Carsetti R (2015) Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings. Vaccine 33:6689–6696. https://doi.org/10.1016/j.vaccine.2015.10.083
CAS
Article
PubMed
Google Scholar
da Rosa Utiyama SR, Nisihara RM, Nass FR, Oliveira NP, Fiedler PT, de Messias-Reason IT (2008) Autoantibodies in patients with Down syndrome: early senescence of the immune system or precocious markers for immunological diseases? J Paediatr Child Health 44:182–186. https://doi.org/10.1111/j.1440-1754.2007.01229.x
Article
PubMed
Google Scholar
Guaraldi F, Rossetto Giaccherino R, Lanfranco F et al (2017) Endocrine autoimmunity in Down’s syndrome. Front Horm Res 48:133–146. https://doi.org/10.1159/000452912
CAS
Article
PubMed
Google Scholar
Karlsson B, Gustafsson J, Hedov G, Ivarsson SA, Anneren G (1998) Thyroid dysfunction in Down’s syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 79:242–245
CAS
Article
Google Scholar
Storm W (1990) Prevalence and diagnostic significance of gliadin antibodies in children with Down syndrome. Eur J Pediatr 149:833–834
CAS
Article
Google Scholar
Fulop T, Larbi A, Dupuis G, le Page A, Frost EH, Cohen AA, Witkowski JM, Franceschi C (2017) Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol 8:1960. https://doi.org/10.3389/fimmu.2017.01960
CAS
Article
PubMed
Google Scholar
Franceschi C, Salvioli S, Garagnani P, de Eguileor M, Monti D, Capri M (2017) Immunobiography and the heterogeneity of immune responses in the elderly: a focus on Inflammaging and trained immunity. Front Immunol 8:982. https://doi.org/10.3389/fimmu.2017.00982
CAS
Article
PubMed
PubMed Central
Google Scholar
Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino CM, Ligotti ME, Zareian N, Accardi G (2019) Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Front Immunol 10:2247. https://doi.org/10.3389/fimmu.2019.02247
CAS
Article
PubMed
PubMed Central
Google Scholar
Ventura MT, Casciaro M, Gangemi S, Buquicchio R (2017) Immunosenescence in aging: between immune cells depletion and cytokines up-regulation. Clinical and Molecular Allergy 15:21. https://doi.org/10.1186/s12948-017-0077-0
CAS
Article
PubMed
Google Scholar
Franceschi C, Bonafè M, Valensin S, Olivieri F, de Luca M, Ottaviani E, de Benedictis G (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254
CAS
Article
Google Scholar
Thomas R, Wang W, Su D-M (2020) Contributions of age-related thymic involution to immunosenescence and inflammaging. Immun Ageing 17:2. https://doi.org/10.1186/s12979-020-0173-8
CAS
Article
PubMed
PubMed Central
Google Scholar
Goronzy JJ, Weyand CM (2019) Mechanisms underlying T cell ageing. Nat Rev Immunol 19:573–583. https://doi.org/10.1038/s41577-019-0180-1
CAS
Article
PubMed
PubMed Central
Google Scholar
Elyahu Y, Hekselman I, Eizenberg-Magar I, et al (2019) Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes. Sci Adv 5:eaaw8330. https://doi.org/10.1126/sciadv.aaw8330
Goronzy JJ, Lee W-W, Weyand CM (2007) Aging and T-cell diversity. Exp Gerontol 42:400–406. https://doi.org/10.1016/j.exger.2006.11.016
CAS
Article
PubMed
PubMed Central
Google Scholar
Goronzy JJ, Weyand CM (2005) T cell development and receptor diversity during aging. Curr Opin Immunol 17:468–475. https://doi.org/10.1016/j.coi.2005.07.020
CAS
Article
PubMed
Google Scholar
Larbi A, Fulop T (2014) From “truly naïve” to “exhausted senescent” T cells: when markers predict functionality. Cytometry A 85:25–35. https://doi.org/10.1002/cyto.a.22351
CAS
Article
PubMed
Google Scholar
Barrena MJ, Echaniz P, Garcia-Serrano C, Cuadrado E (1993) Imbalance of the CD4+ subpopulations expressing CD45RA and CD29 antigens in the peripheral blood of adults and children with Down syndrome. Scand J Immunol 38:323–326
CAS
Article
Google Scholar
Cocchi G, Mastrocola M, Capelli M et al (2007) Immunological patterns in young children with Down syndrome: is there a temporal trend? Acta Paediatr 96:1479–1482. https://doi.org/10.1111/j.1651-2227.2007.00459.x
Article
PubMed
Google Scholar
Cossarizza A, Monti D, Montagnani G, Ortolani C, Masi M, Zannotti M, Franceschi C (1990) Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. Am J Med Genet Suppl 7:213–218
CAS
PubMed
Google Scholar
Joshi AY, Abraham RS, Snyder MR, Boyce TG (2011) Immune evaluation and vaccine responses in Down syndrome: evidence of immunodeficiency? Vaccine 29:5040–5046. https://doi.org/10.1016/j.vaccine.2011.04.060
CAS
Article
PubMed
PubMed Central
Google Scholar
Schoch J, Rohrer TR, Kaestner M, Abdul-Khaliq H, Gortner L, Sester U, Sester M, Schmidt T (2017) Quantitative, phenotypical, and functional characterization of cellular immunity in children and adolescents with Down syndrome. J Infect Dis 215:1619–1628. https://doi.org/10.1093/infdis/jix168
CAS
Article
PubMed
Google Scholar
Trotta MB, Serro Azul JB, Wajngarten M et al (2011) Inflammatory and immunological parameters in adults with Down syndrome. Immun Ageing 8:4. https://doi.org/10.1186/1742-4933-8-4
CAS
Article
PubMed
PubMed Central
Google Scholar
Lockitch G, Singh VK, Puterman ML, Godolphin WJ, Sheps S, Tingle AJ, Wong F, Quigley G (1987) Age-related changes in humoral and cell-mediated immunity in Down syndrome children living at home. Pediatr Res 22:536–540. https://doi.org/10.1203/00006450-198711000-00013
CAS
Article
PubMed
Google Scholar
Guazzarotti L, Trabattoni D, Castelletti E, Boldrighini B, Piacentini L, Duca P, Beretta S, Pacei M, Caprio C, Vigan;ago A, di Natale B, Zuccotti GV, Clerici M (2009) T lymphocyte maturation is impaired in healthy young individuals carrying trisomy 21 (Down syndrome). Am J Intellect Dev Disabil 114:100–109. https://doi.org/10.1352/2009.114.100-109
Article
PubMed
Google Scholar
Pellegrini FP, Marinoni M, Frangione V, Tedeschi A, Gandini V, Ciglia F, Mortara L, Accolla RS, Nespoli L (2012) Down syndrome, autoimmunity and T regulatory cells. Clin Exp Immunol 169:238–243. https://doi.org/10.1111/j.1365-2249.2012.04610.x
CAS
Article
PubMed
PubMed Central
Google Scholar
Murphy M, Epstein LB (1992) Down syndrome (DS) peripheral blood contains phenotypically mature CD3+TCR alpha, beta+ cells but abnormal proportions of TCR alpha, beta+, TCR gamma, delta+, and CD4+ CD45RA+ cells: evidence for an inefficient release of mature T cells by the DS thymus. Clin Immunol Immunopathol 62:245–251
CAS
Article
Google Scholar
Farroni C, Marasco E, Marcellini V, Giorda E, Valentini D, Petrini S, D'Oria V, Pezzullo M, Cascioli S, Scarsella M, Ugazio AG, de Vincentiis GC, Grimsholm O, Carsetti R (2018) Dysregulated miR-155 and miR-125b are related to impaired B-cell responses in Down syndrome. Front Immunol 9:2683. https://doi.org/10.3389/fimmu.2018.02683
CAS
Article
PubMed
PubMed Central
Google Scholar
Waugh KA, Araya P, Pandey A et al (2019) Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type I interferon in Down syndrome. Cell Rep 29:1893–1908.e4. https://doi.org/10.1016/j.celrep.2019.10.038
CAS
Article
PubMed
PubMed Central
Google Scholar
Araya P, Waugh KA, Sullivan KD, Núñez NG, Roselli E, Smith KP, Granrath RE, Rachubinski AL, Enriquez Estrada B, Butcher ET, Minter R, Tuttle KD, Bruno TC, Maccioni M, Espinosa JM (2019) Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity. Proc Natl Acad Sci U S A 116:24231–24241. https://doi.org/10.1073/pnas.1908129116
CAS
Article
PubMed
PubMed Central
Google Scholar
Roat E, Prada N, Lugli E, Nasi M, Ferraresi R, Troiano L, Giovenzana C, Pinti M, Biagioni O, Mariotti M, di Iorio A, Consolo U, Balli F, Cossarizza A (2008) Homeostatic cytokines and expansion of regulatory T cells accompany thymic impairment in children with Down syndrome. Rejuvenation Res 11:573–583. https://doi.org/10.1089/rej.2007.0648
CAS
Article
PubMed
Google Scholar
Franceschi C, Licastro F, Chiricolo M et al (1981) Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down’s syndrome. J Immunol 126:2161–2164
CAS
PubMed
Google Scholar
Park E, Alberti J, Mehta P, Dalton A, Sersen E, Schuller-Levis G (2000) Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down’s syndrome. Clin Immunol 95:62–69. https://doi.org/10.1006/clim.2000.4834
CAS
Article
PubMed
Google Scholar
Karttunen R, Nurmi T, Ilonen J, Surcel HM (1984) Cell-mediated immunodeficiency in Down’s syndrome: normal IL-2 production but inverted ratio of T cell subsets. Clin Exp Immunol 55:257–263
CAS
PubMed
PubMed Central
Google Scholar
Burgio GR, Ugazio AG, Nespoli L, Marcioni AF, Bottelli AM, Pasquali F (1975) Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down’s syndrome at different ages. Eur J Immunol 5:600–603. https://doi.org/10.1002/eji.1830050904
CAS
Article
PubMed
Google Scholar
Cetiner S, Demirhan O, Inal TC, Tastemir D, Sertdemir Y (2010) Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome. Int J Immunogenet 37:233–237. https://doi.org/10.1111/j.1744-313X.2010.00914.x
CAS
Article
PubMed
Google Scholar
Fabris N, Mocchegiani E, Amadio L et al (1984) Thymic hormone deficiency in normal ageing and Down’s syndrome: is there a primary failure of the thymus? Lancet 1:983–986
CAS
Article
Google Scholar
Larocca LM, Piantelli M, Valitutti S, Castellino F, Maggiano N, Musiani P (1988) Alterations in thymocyte subpopulations in Down’s syndrome (trisomy 21). Clin Immunol Immunopathol 49:175–186
CAS
Article
Google Scholar
Murphy M, Lempert MJ, Epstein LB (1990) Decreased level of T cell receptor expression by Down syndrome (trisomy 21) thymocytes. Am J Med Genet Suppl 7:234–237
CAS
PubMed
Google Scholar
Musiani P, Valitutti S, Castellino F, Larocca LM, Maggiano N, Piantelli M (1990) Intrathymic deficient expansion of T cell precursors in Down syndrome. Am J Med Genet Suppl 7:219–224
CAS
PubMed
Google Scholar
Papadopoulos N, Simopoulos C, Venizelos J et al (2003) Fetal thymic medulla functional alterations in Down’s syndrome. Minerva Med 94:181–185
CAS
PubMed
Google Scholar
Prada N, Nasi M, Troiano L, Roat E, Pinti M, Nemes E, Lugli E, Ferraresi R, Ciacci L, Bertoni D, Biagioni O, Gibertoni M, Cornia C, Meschiari L, Gramazio E, Mariotti M, Consolo U, Balli F, Cossarizza A (2005) Direct analysis of thymic function in children with Down’s syndrome. Immun Ageing 2:4. https://doi.org/10.1186/1742-4933-2-4
CAS
Article
PubMed
PubMed Central
Google Scholar
Frasca D, Blomberg BB (2009) Effects of aging on B cell function. Curr Opin Immunol 21:425–430. https://doi.org/10.1016/j.coi.2009.06.001
CAS
Article
PubMed
PubMed Central
Google Scholar
Verstegen RHJ, Kusters MAA, Gemen EFA, DE Vries E (2010) Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help. Pediatr Res 67:563–569. https://doi.org/10.1203/PDR.0b013e3181d4ecc1
CAS
Article
PubMed
Google Scholar
Carsetti R, Valentini D, Marcellini V, Scarsella M, Marasco E, Giustini F, Bartuli A, Villani A, Ugazio AG (2015) Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome. Eur J Immunol 45:903–914. https://doi.org/10.1002/eji.201445049
CAS
Article
PubMed
Google Scholar
Verstegen RHJ, Driessen GJ, Bartol SJW et al (2014) Defective B-cell memory in patients with Down syndrome. J Allergy Clin Immunol 134:1346–1353.e9. https://doi.org/10.1016/j.jaci.2014.07.015
CAS
Article
PubMed
Google Scholar
Chaushu S, Yefenof E, Becker A, Shapira J, Chaushu G (2002) Severe impairment of secretory Ig production in parotid saliva of Down syndrome individuals. J Dent Res 81:308–312. https://doi.org/10.1177/154405910208100504
CAS
Article
PubMed
Google Scholar
Bloemers BLP, van Bleek GM, Kimpen JLL, Bont L (2010) Distinct abnormalities in the innate immune system of children with Down syndrome. J Pediatr 156:804–809, 809.e1-809.e5. https://doi.org/10.1016/j.jpeds.2009.12.006
CAS
Article
PubMed
Google Scholar
Camous X, Pera A, Solana R, Larbi A (2012) NK cells in healthy aging and age-associated diseases. J Biomed Biotechnol 2012:195956–195958. https://doi.org/10.1155/2012/195956
CAS
Article
PubMed
PubMed Central
Google Scholar
Gounder SS, Abdullah BJJ, Radzuanb NEIBM, Zain FDBM, Sait NBM, Chua C, Subramani B (2018) Effect of aging on NK cell population and their proliferation at ex vivo culture condition. Anal Cell Pathol (Amst) 2018:1–6. https://doi.org/10.1155/2018/7871814
CAS
Article
Google Scholar
Cossarizza A, Ortolani C, Forti E, Montagnani G, Paganelli R, Zannotti M, Marini M, Monti D, Franceschi C (1991) Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down’s syndrome. Blood 77:1263–1270
CAS
Article
Google Scholar
de Hingh YCM, van der Vossen PW, Gemen EFA, Mulder AB, Hop WCJ, Brus F, de Vries E (2005) Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr 147:744–747. https://doi.org/10.1016/j.jpeds.2005.07.022
Article
PubMed
Google Scholar
Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128:92–105. https://doi.org/10.1016/j.mad.2006.11.016
CAS
Article
PubMed
Google Scholar
Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69(Suppl 1):S4–S9. https://doi.org/10.1093/gerona/glu057
Article
PubMed
Google Scholar
Carta MG, Serra P, Ghiani A, Manca E, Hardoy MC, del Giacco GS, Diaz G, Carpiniello B, Manconi PE (2002) Chemokines and pro-inflammatory cytokines in Down’s syndrome: an early marker for Alzheimer-type dementia? Psychother Psychosom 71:233–236. https://doi.org/10.1159/000063649
Article
PubMed
Google Scholar
Iulita MF, Ower A, Barone C, Pentz R, Gubert P, Romano C, Cantarella RA, Elia F, Buono S, Recupero M, Romano C, Castellano S, Bosco P, di Nuovo S, Drago F, Caraci F, Cuello AC (2016) An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: relation to cognitive decline and longitudinal evaluation. Alzheimers Dement 12:1132–1148. https://doi.org/10.1016/j.jalz.2016.05.001
Article
PubMed
Google Scholar
Nateghi Rostami M, Douraghi M, Miramin Mohammadi A, Nikmanesh B (2012) Altered serum pro-inflammatory cytokines in children with Down’s syndrome. Eur Cytokine Netw 23:64–67. https://doi.org/10.1684/ecn.2012.0307
CAS
Article
PubMed
Google Scholar
Rodrigues R, Debom G, Soares F, Machado C, Pureza J, Peres W, de Lima Garcias G, Duarte MF, Schetinger MRC, Stefanello F, Braganhol E, Spanevello R (2014) Alterations of ectonucleotidases and acetylcholinesterase activities in lymphocytes of Down syndrome subjects: relation with inflammatory parameters. Clin Chim Acta 433:105–110. https://doi.org/10.1016/j.cca.2014.03.002
CAS
Article
PubMed
Google Scholar
Zaki ME, El-Bassyouni HT, Tosson AMS et al (2017) Coenzyme Q10 and pro-inflammatory markers in children with Down syndrome: clinical and biochemical aspects. J Pediatr 93:100–104. https://doi.org/10.1016/j.jped.2016.04.012
Article
Google Scholar
Sullivan KD, Evans D, Pandey A, Hraha TH, Smith KP, Markham N, Rachubinski AL, Wolter-Warmerdam K, Hickey F, Espinosa JM, Blumenthal T (2017) Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. Sci Rep 7:14818. https://doi.org/10.1038/s41598-017-13858-3
CAS
Article
PubMed
PubMed Central
Google Scholar
Zhang Y, Che M, Yuan J, Yu Y, Cao C, Qin XY, Cheng Y (2017) Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis. Oncotarget 8:84489–84496. https://doi.org/10.18632/oncotarget.21060
Article
PubMed
PubMed Central
Google Scholar
Sullivan KD, Lewis HC, Hill AA, Pandey A, Jackson LP, Cabral JM, Smith KP, Liggett LA, Gomez EB, Galbraith MD, DeGregori J, Espinosa JM (2016) Trisomy 21 consistently activates the interferon response. Elife 5. https://doi.org/10.7554/eLife.16220
de Weerd NA, Nguyen T (2012) The interferons and their receptors-distribution and regulation. Immunol Cell Biol 90:483–491. https://doi.org/10.1038/icb.2012.9
CAS
Article
PubMed
PubMed Central
Google Scholar
Wilcock DM (2012) Neuroinflammation in the aging Down syndrome brain; lessons from Alzheimer’s disease. Curr Gerontol Geriatr Res 2012:170276–170210. https://doi.org/10.1155/2012/170276
Article
PubMed
PubMed Central
Google Scholar
Wilcock DM, Hurban J, Helman AM, Sudduth TL, McCarty KL, Beckett TL, Ferrell JC, Murphy MP, Abner EL, Schmitt FA, Head E (2015) Down syndrome individuals with Alzheimer’s disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer’s disease. Neurobiol Aging 36:2468–2474. https://doi.org/10.1016/j.neurobiolaging.2015.05.016
CAS
Article
PubMed
PubMed Central
Google Scholar
Kusters MAA, Gemen EFA, Verstegen RHJ, Wever PC, de Vries E (2010) Both normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome T lymphocytes. Pediatr Res 67:557–562. https://doi.org/10.1203/PDR.0b013e3181d4eca3
Article
PubMed
Google Scholar
Kusters MA, Verstegen RH, de Vries E (2011) Down syndrome: is it really characterized by precocious immunosenescence? Aging Dis 2:538–545
PubMed
PubMed Central
Google Scholar
Lorenzo LPE, Shatynski KE, Clark S, Yarowsky PJ, Williams MS (2013) Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome. Immunology 139:447–458. https://doi.org/10.1111/imm.12092
CAS
Article
PubMed
PubMed Central
Google Scholar
Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, Franceschi C, Lithgow GJ, Morimoto RI, Pessin JE, Rando TA, Richardson A, Schadt EE, Wyss-Coray T, Sierra F (2014) Geroscience: linking aging to chronic disease. Cell 159:709–713. https://doi.org/10.1016/j.cell.2014.10.039
CAS
Article
PubMed
PubMed Central
Google Scholar
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153:1194–1217. https://doi.org/10.1016/j.cell.2013.05.039
CAS
Article
PubMed
PubMed Central
Google Scholar
Cairney CJ, Sanguinetti G, Ranghini E, Chantry AD, Nostro MC, Bhattacharyya A, Svendsen CN, Keith WN, Bellantuono I (2009) A systems biology approach to Down syndrome: identification of Notch/Wnt dysregulation in a model of stem cells aging. Biochim Biophys Acta 1792:353–363. https://doi.org/10.1016/j.bbadis.2009.01.015
CAS
Article
PubMed
Google Scholar
Liu B, Filippi S, Roy A, Roberts I (2015) Stem and progenitor cell dysfunction in human trisomies. EMBO Rep 16:44–62. https://doi.org/10.15252/embr.201439583
CAS
Article
PubMed
Google Scholar
Adorno M, Sikandar S, Mitra SS, Kuo A, Nicolis di Robilant B, Haro-Acosta V, Ouadah Y, Quarta M, Rodriguez J, Qian D, Reddy VM, Cheshier S, Garner CC, Clarke MF (2013) Usp16 contributes to somatic stem-cell defects in Down’s syndrome. Nature 501:380–384. https://doi.org/10.1038/nature12530
CAS
Article
PubMed
PubMed Central
Google Scholar
Arbuzova S, Hutchin T, Cuckle H (2002) Mitochondrial dysfunction and Down’s syndrome. Bioessays 24:681–684. https://doi.org/10.1002/bies.10138
Article
PubMed
Google Scholar
Caracausi M, Ghini V, Locatelli C, Mericio M, Piovesan A, Antonaros F, Pelleri MC, Vitale L, Vacca RA, Bedetti F, Mimmi MC, Luchinat C, Turano P, Strippoli P, Cocchi G (2018) Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism. Sci Rep 8:2977. https://doi.org/10.1038/s41598-018-20834-y
CAS
Article
PubMed
PubMed Central
Google Scholar
Conte M, Ostan R, Fabbri C, Santoro A, Guidarelli G, Vitale G, Mari D, Sevini F, Capri M, Sandri M, Monti D, Franceschi C, Salvioli S (2018) Human aging and longevity are characterized by high levels of mitokines. J Gerontol A Biol Sci Med Sci 74:600–607. https://doi.org/10.1093/gerona/gly153
CAS
Article
Google Scholar
Zana M, Szécsényi A, Czibula A, Bjelik A, Juhász A, Rimanóczy Á, Szabó K, Vetró Á, Szűcs P, Várkonyi Á, Pákáski M, Boda K, Raskó I, Janka Z, Kálmán J (2006) Age-dependent oxidative stress-induced DNA damage in Down’s lymphocytes. Biochem Biophys Res Commun 345:726–733. https://doi.org/10.1016/j.bbrc.2006.04.167
CAS
Article
PubMed
Google Scholar
Franceschi C, Monti D, Scarfí MR et al (1992) Genomic instability and aging. Studies in centenarians (successful aging) and in patients with Down’s syndrome (accelerated aging). Ann N Y Acad Sci 663:4–16
CAS
Article
Google Scholar
Maluf SW, Erdtmann B (2001) Genomic instability in Down syndrome and Fanconi anemia assessed by micronucleus analysis and single-cell gel electrophoresis. Cancer Genet Cytogenet 124:71–75
CAS
Article
Google Scholar
Morawiec Z, Janik K, Kowalski M, Stetkiewicz T, Szaflik J, Morawiec-Bajda A, Sobczuk A, Blasiak J (2008) DNA damage and repair in children with Down’s syndrome. Mutat Res 637:118–123. https://doi.org/10.1016/j.mrfmmm.2007.07.010
CAS
Article
PubMed
Google Scholar
Tiano L, Littarru GP, Principi F, Orlandi M, Santoro L, Carnevali P, Gabrielli O (2005) Assessment of DNA damage in Down syndrome patients by means of a new, optimised single cell gel electrophoresis technique. Biofactors 25:187–195
CAS
Article
Google Scholar
Vaziri H, Schächter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D, Harley CB (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52:661–667
CAS
PubMed
PubMed Central
Google Scholar
Kerkel K, Schupf N, Hatta K, Pang D, Salas M, Kratz A, Minden M, Murty V, Zigman WB, Mayeux RP, Jenkins EC, Torkamani A, Schork NJ, Silverman W, Croy BA, Tycko B (2010) Altered DNA methylation in leukocytes with trisomy 21. PLoS Genet 6:e1001212. https://doi.org/10.1371/journal.pgen.1001212
CAS
Article
PubMed
PubMed Central
Google Scholar
Bacalini MG, Gentilini D, Boattini A, Giampieri E, Pirazzini C, Giuliani C, Fontanesi E, Scurti M, Remondini D, Capri M, Cocchi G, Ghezzo A, del Rio A, Luiselli D, Vitale G, Mari D, Castellani G, Fraga M, di Blasio AM, Salvioli S, Franceschi C, Garagnani P (2015) Identification of a DNA methylation signature in blood cells from persons with Down syndrome. Aging (Albany NY) 7:82–96. https://doi.org/10.18632/aging.100715
CAS
Article
Google Scholar
Ciccarone F, Valentini E, Malavolta M, Zampieri M, Bacalini MG, Calabrese R, Guastafierro T, Reale A, Franceschi C, Capri M, Breusing N, Grune T, Moreno-Villanueva M, Bürkle A, Caiafa P (2018) DNA hydroxymethylation levels are altered in blood cells from Down syndrome persons enrolled in the MARK-AGE project. J Gerontol A Biol Sci Med Sci 73:737–744. https://doi.org/10.1093/gerona/glx198
CAS
Article
PubMed
Google Scholar